Apraclonidine. In: CAS Common Chemistry. Abgerufen am 18. Mai 2022.
doi.org
Jens Schmitz, Ulrike Holzgrabe: Die Entwicklung selektiver α2-Rezeptor-Agonisten: Arterielle Hypertonie und viele andere Indikationen. In: Pharmazie in unserer Zeit. Band40, Nr.6, November 2011, S.496–502, doi:10.1002/pauz.201100446.
Jose Morales, Sandra M. Brown, Aziz S. Abdul-Rahim, Craig E. Crosson: Ocular Effects of Apraclonidine in Horner Syndrome. In: Archives of Ophthalmology. Band118, Nr.7, 1. Juli 2000, S.951–954, doi:10.1001/pubs.Ophthalmol.
Ping-Heng Tan, Hartmut Buerkle, Jiin-Tsuey Cheng, Hsun-Chang Shih, Wen-Ying Chou: Double-Blind Parallel Comparison of Multiple Doses of Apraclonidine, Clonidine, and Placebo Administered Intra-Articularly to Patients Undergoing Arthroscopic Knee Surgery. In: The Clinical Journal of Pain. Band20, Nr.4, 2004, S.256–260, doi:10.1097/00002508-200407000-00007.
Patrick Watts, Denise Satterfield, May Kim Lim: Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants. In: Journal of American Association for Pediatric Ophthalmology and Strabismus. Band11, Nr.3, 1. Juni 2007, S.282–283, doi:10.1016/j.jaapos.2007.02.015.